Send the following on WhatsApp
Continue to ChatBillion dollar target for biologics biz by FY22 unrealistic, but we would soon return to high growth trajectory: Kiran Mazumdar Shaw - Economic Times https://www.indiafinancenews.com/billion-dollar-target-for-biologics-biz-by-fy22-unrealistic-but-we-would-soon-return-to-high-growth-trajectory-kiran-mazumdar-shaw-economic-times/